Cardio Diagnostics Receives Preliminary Medicare Pricing From CMS For AI-Powered Cardiovascular Tests, Marking Key Milestone Toward Securing Medicare Reimbursement For PrecisionCHD And Epi+Gen CHD
心脏诊断收到康哲药业为人工智能驱动的心血管测试制定的初步医疗保险价格,这是向确保PrecisionCHD和Epi+Gen CHD获得医疗保险报销的关键里程碑。